To view the poster, please click on the title of presentation. Note; only the posters provided are available.

Name	Title of Presentation	Poster  Number	Theme
Kat Byron	Deadly Sexy Health; Sexual Sealth Promotion in the Victorian Aboriginal Community Controlled Health Setting	P01.01	Sexual health of Indigenous and minority ethnic populations
Bradley Whitton	a regional sexual and reproductive health campaign providing clinical education and health promotion activites in 2015 for Aboriginal Health Services and communities in the western district of Victoria	P01.02	Sexual health of Indigenous and minority ethnic populations
Brent Mackie	Developing a campaign to encourage Aboriginal Gay men to access HIV rapid testing.	P01.03	Sexual health of Indigenous and minority ethnic populations
Marisa Gilles	Equity in health care delivers the goods	P01.05	Sexual health of Indigenous and minority ethnic populations
Sabina Wagle	Roles of NGOs/CSOs in HIV/AIDS prevention, treatment, care and support for mobile population in greater Mekong sub-regions/ASEAN countries.	P01.06	Sexual health of Indigenous and minority ethnic populations
Judith Dean	Young Sudanese Queenslanders's sexual health knowledge and behaviours may place them at risk - culturally informed sexuality education is needed.	P01.07	Sexual health of Indigenous and minority ethnic populations
Catherine MacPhail	Structural and Contextual Factors in the Sexual Health of Adolescent Aboriginal Australians: A Systematic Review	P01.08	Sexual health of Indigenous and minority ethnic populations
Thomas Gift	Trends in Selected Measures of Racial and Ethnic Disparities in Gonorrhea and Syphilis in the United States, 1981-2012	P01.09	Sexual health of Indigenous and minority ethnic populations
Quang Tran	HIV/STI Infections and Risk Behavior Among Dao Ethnic People In 2006 And 2012 in Viet Nam	P01.10	Sexual health of Indigenous and minority ethnic populations
Sonali Wayal	Understanding the greater burden of STIs among Black Caribbeans in the UK: evidence from a systematic review	P01.11	Sexual health of Indigenous and minority ethnic populations
Sonali Wayal	Systematic Review and Meta-Analysis of Randomized Control Trials of Interactive Digital Interventions for Sexual Health Promotion	P02.01	New media in STI prevention
Mary Florance	Another Digi-Gap! Integrating Multifaceted Triaging Approaches to Assist and Speed Technological Transition to Electronic Medical Documentation and Booking Systems	P02.02	New media in STI prevention
Mark Gilbert	"Click Yes to Consent": Can we Achieve Informed Consent for Online Testing for Sexually Transmitted Infections?	P02.03	New media in STI prevention
Mark Gilbert	Acceptability of online resources for STI partner notification: who would use what in the toolkit?	P02.04	New media in STI prevention
Mark Gilbert	Sexual Health Literacy - An Emerging Framework for Research and Intervention to Improve Sexual Health for Gay Men	P02.05	New media in STI prevention
Khine Soe Lin	Identities in Motion: Cyberspace and Myanmar men having sex with men	P02.06	New media in STI prevention
Yu-Hsiang Hsieh	Utilization of risk score tool of internet I Want the Kit (IWTK) home self-collection program for STIs in males	P02.07	New media in STI prevention
Elizabeth Fearon	Age of friends and norms about sexual behaviour are associated with HIV and HSV-2 status amongst young South African women in the HPTN 068 study	P03.01	Adolescent sexual health
Adekemi Sekoni	STI and HIV knowledge, prevalence and related behavior among young female traders in an urban slum in Lagos Nigeria	P03.02	Adolescent sexual health
Margaret Hammerschlag	Seroprevalence of Chlamydia Trachomatis in American Children and Adolescents - Implications for Vaccine Development	P03.03	adolescent sexual health
Margaret Hammerschlag	The impact of universal Chlamydia trachomatis (CT) screening during pregnancy on seroepidemiology of chlamydial infection in children, 1991-2013	P03.04	adolescent sexual health
Lucy Watchirs Smith	Chlamydia Re-Testing at Sexual Health Clinics has increased but further Initiatives are Needed for Young People	P03.05	adolescent sexual health
Oluwagbemiga Adeyemi	Sexual Exchanges and Coercion among Undergraduate Students in Nigeria: Implications for Sexually Transmitted Infections	P03.06	Adolescent sexual health
Opeyemi Agbaje	Mitigating the Impact of HIV/AIDS among in and out of school youth through peer education using Family  Life HIV Education in Federal Capital Territory Abuja Nigeria	P03.07	Adolescent sexual health
Suresh Badhan	Prevailing myths and misconceptions and effect of intervention in changing the attitude of secondary school students of South Delhi regarding HIV/AIDS and positive persons.	P03.08	Adolescent sexual health
Michelle Bonner	Implementing Sexual Health 'Spaced Education' for Undergraduate Medical Students in New South Wales, Australia	P03.09	Adolescent sexual health
Emily Wheeler	Working Together- Primary Health Care Nurses Taking the Lead in Sexual Health Care	P03.10	Adolescent sexual health
Hayley Denison	Knowledge about sexually transmitted infections among a New Zealand university population	P03.11	Adolescent sexual health
Hayley Denison	Recruiting to sexual health studies: possible strategies identified through focus group discussions	P03.12	Adolescent sexual health
Patricia Dittus	The Project Connect parental monitoring intervention: Population-level effects on adolescent perceptions of parental enforcement of family rules	P03.13	Adolescent sexual health
Suzanna Francis	High prevalence of Lactobacillis Crispatus among adolescent girls attending secondary schools in Tanzania	P03.14	Adolescent sexual health
Rachel Fuller	Peer Education in Practice: An Example of a Youth-led Sexual Health Program	P03.15	Adolescent sexual health
Suzanne Garland	Sexual Abuse Reported by Young Australian Women	P03.16	Adolescent sexual health
Sandra Gregson	The Victorian Aboriginal Medical Service (VAHS) conducted a young people's sexual health and sexually transmissable infections and blood borne virus (STI/BBV) knowledge, attitudes and behaviour survey in 2014	P03.17	Adolescent sexual health
Muhammad Hoque	knowledge regarding hiv/aids and views on hiv testing before marrying migrant workers among rural higher secondary school students in bangladesh	P03.18	Adolescent sexual health
Linnet Masese	Screening for Sexually Transmitted Infections in Adolescent Girls and Young Women in Mombasa, Kenya	P03.19	adolescent sexual health
Pratima Mittal	High Risk Factors and their Association with SexuHally Transmitted Infections among Asymptomatic Pregnant Adolescent	P03.20	adolescent sexual health
Meagan Roberts	Be safe. stay well: four videos to educate international students on sexual health and staying safe in Australia	P03.21	Adolescent sexual health
Meagan Roberts	Infection Protection: The development of an interactive, online game to educate young people about sexual health and relationships	P03.22	Adolescent sexual health
Ni Wayan Septarini	Human Immunodeficiency Virus infection risk behaviours among school students in the capital city of a famous travel destination, Bali	P03.23	Adolescent sexual health
Deepak Sharma	Effect of media on adolescent girls "HIV/AIDS comprehensive knowledge" and "stigmatizing attitude" towards people living with HIV/AIDS	P03.24	Adolescent sexual health
Solomon Sisay	Perception of High School Students on Risk for Acquiring HIV and Utilization of Voluntary Counseling and Testing  Service for HIV in Debre-Berhan Town, Ethiopia: A Quantitative Cross-Sectional Study	P03.25	Adolescent sexual health
George Wanje	Parents' and Teachers' Views on Adolescents' Sexual Health to Inform the Development of a Screening Intervention for Sexually Transmitted Infections: A Qualitative Study	P03.26	Adolescent sexual health
Devon Haag	Similarities and Differences in Perceptions of Models for Online Partner Notification for Sexually Transmitted Infections: Potential Users Versus Care Providers	P04.01	Partners, places and STI risk
Marc Steben	Partner Notification in North America: a historical account	P04.02	Partners, places and STI risk
Wei Sheng Tan	Which partner notification method do patients prefer? Results of a patient preference survey at the national STI clinic in Singapore	P04.03	Partners, places and STI risk
Sarah Huffam	Chlamydia infection in males and females reporting sex with partners with chlamydia.	P04.04	Partners, places and STI risk
Krishneel Dutt	High prevalence of rectal gonorrhoea among men reporting contact with men with gonorrhoea: implications for epidemiological treatment	P04.05	Partners, places and STI risk
Jason Wong	Partner number and outcomes of partner notification among gay, bisexual, and other men who have sex with men with infectious syphilis in British Columbia, Canada	P04.06	Partners, places and STI risk
Vincent Cornelisse	"Summer Loving": An Analysis of Seasonal Differences in Sexual Behaviour and Sexually Transmissible Infections"	P04.07	Partners, places and STI risk
Errol Fields	Sex Partner Meeting Venues and HIV Transmission Risk Factors among Newly Diagnosed HIV-Infected Urban MSM: Implications for Targeted Control Strategies	P04.08	Partners, places and STI risk
Hanne Harbison	Association of gender of sexual partners with women's sexually transmitted infection risk	P04.09	Partners, places and STI risk
Ryosuke Omori	The link between population sexual behavior and HIV prevalence in sub-Saharan Africa	P04.10	Partners, places and STI risk
Ryosuke Omori	Estimation of non-cohabiting sex partnering in sub-Saharan Africa	P04.11	Partners, places and STI risk
Steve Simpson, Jr.	Front-to-back wiping and dabbing behaviours post-toilet are significantly associated with anal neoplasia & HR-HPV carriage in women with a previous HPV-mediated gynaecological neoplasia	P04.12	Partners, places and STI risk
Steve Simpson, Jr.	The sexual health literacy of the student population of the University of Tasmania: results of the RUSSL study	P04.13	Partners, places and STI risk
Jennie Connor	Prevalence and consistency of opinions on same-sex partnerships over 12 years in a New Zealand birth cohort	P04.14	Partners, places and STI risk
Anna Yeung	Sexual behaviour & STI testing/reporting down under: findings from the second Australian study of health and relationships	P04.15	Partners, places and STI risk
Anna Yeung	"It opened my eyes" - GPs' opinions on the Australian Chlamydia Control Effectiveness Pilot (ACCEPt)	P04.16	Partners, places and STI risk
Alison Noris	Intravaginal practices among rural Malawian women	P04.17	Partners, places and STI risk
Alison Noris	Are Intravaginal Practices Associated with Precancerous Lesions and HPV Infection?	P04.18	Partners, places and STI risk
Jennie Connor	Alcohol involvement in sexual behaviour and adverse sexual health outcomes from 26 to 38 years of age.	P04.19	Partners, places and STI risk
Dennis Fortenberry	Incident Sexually Transmitted Infection and Post-Infection Partner Change	P04.20	Partners, places and STI risk
Dennis Fortenberry	Event-Level Analysis of Condom Use and Love during Transactional Vaginal Intercourse among Women Living in the Midwestern United States	P04.21	Partners, places and STI risk
Jacky Jennings	Sex Partner Meeting Places Over Time Among Newly HIV Diagnosed Men Who Have Sex With Men (MSM) In Baltimore, Maryland	P04.22	Partners, places and STI risk
Catherine Mercer	Mind the gap! Biological and behavioural concurrency and their potential for STI transmission in the British population.	P04.23	Partners, places and STI risk
Marjan Meshkati	Evaluation of Prevalence of STIS between Women Referred to Counseling and Harm Reduction Center for Vulnerable Women” in Isfahan – IRAN 2014"	P04.24	Partners, places and STI risk
Puneet Misra	Sexual Health problems among adult males of North India: A community based study	P04.25	Partners, places and STI risk
Achyuta Nori	Robustness of Capturing Behavioural and Sexual Lifestyle Data for a Complex Clinical Study Using Internet-Based Computer Assisted Self-Interview	P04.26	Partners, places and STI risk
Milan Satcher	Partner-Level Associated Factors for Insertive and Receptive Condomless Anal Intercourse among Transgender Women in Lima, Peru	P04.27	Partners, places and STI risk
Milan Satcher	Exploring Contextual Differences for Receptive and Insertive Role Strain among Transgender Women and Men Who Have Sex With Men in Lima, Peru	P04.28	Partners, places and STI risk
Wei Guo	Relationship between Cigarette Smoking and Health Risk Behaviors among Chinese Youth: Findings from a National Survey	P04.29	Partners, places and STI risk
Nikki Jeal	A systematic review of interventions to reduce illicit drug use in female drug-dependent street sex workers	P04.30	Partners, places and STI risk
Faridoon Qayoumi	STUDY AMONG INJECTABLE DRUGS USERS (IDUs)	P04.31	Partners, places and STI risk
Carol Reid	Motivational interviewing for people with chronic viral hepatitis and who drink alcohol: a randomised controlled trial.	P04.32	Partners, places and STI risk
Uma Chaudhry	Drug target to inhibitor (DT2I) approach of combating increasing drug resistance in Neisseria gonorrhoeae.	P05.01	Antimicrobial resistance
Tania Crucitti	Neisseria Gonorrhoeae strain types and antibiotic susceptibility in Belgium: national data from 2013	P05.02	Antimicrobial resistance
Tania Crucitti	Performance of Two Enzyme and One Strip Immune Assay for the Detection of IgM anti-Treponema pallidum Antibodies.	P05.03	Antimicrobial resistance
Paula Dixon	Antimicrobial Susceptibilities of Persons with Gonorrhea at Multiple Sites are Accurately Reflected by Urogenital Specimens	P05.04	Antimicrobial resistance
I Putu Yuda Hananta	Neisseria Gonorrhoeae in Indonesia: Prevalence and Antimicrobial Susceptibility among STI Clinics Patients in Jakarta, Yogyakarta and Denpasar	P05.05	Antimicrobial resistance
I Putu Yuda Hananta	Prolonged Infection of Pharyngeal Gonorrhea after Treatment with Ceftriaxone	P05.06	Antimicrobial resistance
Neeraj Mahajan	Neisseria Gonorrhoeae Multiantigen Sequence Typing (NG-MAST) of Isolates Collected from STD Patients in Delhi, India	P05.07	Antimicrobial resistance
Sunanta Nabu	Beta-Lactam Antibiotics Induce Protein Expression Changes in Neisseria Gonorrhoeae Revealed by a Proteomic Approach	P05.08	Antimicrobial resistance
Magnus Unemo	Phenotypic, Genetic and Genomic Characterization of The 2015 WHO Neisseria Gonorrhoeae Reference Strains for Quality Assurance of Laboratory Investigations Globally	P05.09	Antimicrobial resistance
Klaus Jensen	Antimicrobial Resistance of Neisseria Gonorrhoea in Germany, Results from the Gonococcal Resistance Network (GORENET)	P05.10	Antimicrobial resistance
Ryoichi Hamasuna	Antimicrobial Susceptibility of Neisseria Gonorrhoeae Strains from Male Urethritis in Japan: Surveillance at 2012-2013	P05.11	Antimicrobial resistance
Ryoichi Hamasuna	Analysis of Bacterial Flora of the Urine Specimens from Male Patients with Urethritis by the Clone Library Method Based on the 16s Rrna Gene	P05.12	Antimicrobial resistance
Damon Getman	Prevalence and Anatomical Distribution of Mycoplasma genitalium Macrolide Resistance Markers from Subjects Enrolled in a Multi-center US Clinical Study	P05.13	Antimicrobial resistance
Bronwyn Joubert	Minimum inhibitory concentrations of metronidazole and tinidazole against trichomonas vaginalis	P05.14	Antimicrobial resistance
Valentina Dona	Ureaplasma spp. Isolated from genital samples in Switzerland: susceptibility patterns, resistance genes, and sequence type distribution	P05.15	Antimicrobial resistance
Hanneke Borgdorff	The vaginal microbiome of women residing in Amsterdam: association with ethnicity.	P06.01	Genital microbiome
Hanneke Borgdorff	The cervicovaginal microbiome before and after HIV-seroconversion	P06.02	Genital microbiome
Catriona Bradshaw	Increased G. vaginalis clade diversity is associated with penile vaginal sex and bacterial vaginosis	P06.03	Genital microbiome
Vicky Jespers	Gardnerella vaginalis presence in vaginal dysbiosis: A secondary analysis	P06.04	Genital microbiome
Jordan Karanja Kyongo	Dynamics of Vaginal Immune Correlates and Microbiota in Women from Sub-Saharan Africa	P06.05	Genital microbiome
Bing Ma	Azythromycin treatment for Chlamydia trachomatis is associated with vaginal microbiota lacking protective Lactobacillus spp.	P06.06	Genital microbiome
Jason Bell	The Effects of Contraception on The Vaginal Microbiota	P06.07	Genital microbiome
May Beamer	The Association between Free Glycogen in the Vaginal Fluid and Colonization by Lactobacilli	P06.08	Genital microbiome
Laura Breshears	Lactobacillus Crispatus Inhibits Growth of Gardnerella Vaginalis and Neisseria Gonorrhoeae on a Porcine Vaginal Mucosa Model	P06.09	Genital microbiome
Gilda Tachedjian	Lactic Acid Dampens Inflammatory Responses Elicited by Microbial TLR Agonists from Vaginal and Cervical Epithelial Cells	P06.10	Genital microbiome
Jennifer Balkus	The impact of periodic presumptive treatment for vaginal infections on the vaginal microbiome among women participating in the Preventing Vaginal Infections trial	P06.11	Genital microbiome
Melissa Herbst-Kralovetz	Human IL-36 Gamma as an Indicator of Vaginal Infection and Promoter of Mucosal Inflammation	P06.12	Genital microbiome
Shaun Barnabas	Inflammatory cytokine biomarkers identify women with asymptomatic genital infections that increase the risk of HIV infection	P06.13	Genital microbiome
Cathy Watson	The Effect Of Sexual Intercourse on Vaginal Colonisation of Candida	P06.14	Genital microbiome
Sepehr Tabrizi	The Stability of the Vaginal Microbiome in Relation to New Sexual Experiences	P06.15	Genital microbiome
sepehr Tabrizi	Mycoplasma Genitalium Testing Pattern and Infection Rates Over a Six Year Period in Melbourne, Australia	P07.01	STI/ HIV diagnosis
sepehr Tabrizi	Evaluation of the Hologic Transcription Mediated Amplification Assay for Detection of Mycoplasma Genitalium from Urine Samples	P07.02	STI/ HIV diagnosis
David Pearce	Clinical Performance Evaluation of A New, Rapid Point-Of-Care System For Detecting Chlamydia Trachomatis	P07.03	STI/HIV diagnosis
Louise Causer	New Molecular Point-Of-Care Test Improves Timeliness of Treatment for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoea (NG) in a Remote Aboriginal Health Clinic	P07.04	STI/HIV diagnosis
Sunil Sethi	Utility of pooled urine samples for detection of Chlamydia trachomatis infection in asymptomatic pregnant  women  in northern India	P07.05	STI/HIV diagnosis
Ruth Mackay	A Low Cost, Hand-Held Point of Care Molecular Diagnostic Device for Sexually Transmitted Infections	P07.06	STI/HIV diagnosis
Elisa Mokany	Multiplexing STI causing pathogens using PlexPCRTM: superior multiplexing capability	P07.07	STI/HIV diagnosis
Daman Saluja	Designing of Molecular Beacon Based Polymerase Chain Reaction Method as an Unconventional Low Cost Diagnostic Assay for Sexually Transmitted Diseases	P07.08	STI/HIV diagnosis
Lisa Cosentino	A Validation Study of the Cepheid Xpert CT/NG for Detecting Chlamydia Trachomatis and Neisseria Gonorrhoeae in Rectal Samples	P07.09	STI/HIV diagnosis
Daniel Golparian	Evaluation of the New BD MAX GC Real Time PCR Assay, Analytically and as a Supplementary rest to the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Setection of Neisseria Gonorrhoeae	P07.10	STI/HIV diagnosis
Christiane Honisch	Whole Genome Sequencing Characterization of a Unique Neisseria strain Generating a Positive Result with the cobas® CT/NG Test	P07.11	STI/HIV diagnosis
Melanie Bissessor	Factors influencing the detection of neisseria gonorrhoeae from the tonsils and posterior oropharynx	P07.12	STI/HIV diagnosis
Jeremy Chow	Detection of Treponema Pallidum DNA from Whole Blood and Earlobe Specimens in Patients from Two STI Clinics in Lima, Peru	P07.13	STI/HIV diagnosis
Jane Nicholls	Aptima TV NAAT Performance in GUM Clinic and Primary Care in the UK	P07.14	STI/HIV diagnosis
Leyna Chunaifa	Reability and Validity on Bacterial Vaginosis (BV) Screening among Sexual Workers- Baturraden, Banyumas District, Central Java, Indonesia 2014	P07.15	STI/HIV diagnosis
Liselotte Hardy	A Fruitful Alliance: the Synergy between Atopobium vaginae and Gardnerella vaginalis in Bacterial Vaginosis-Associated Biofilm	P07.16	STI/HIV diagnosis
Wei-Ming Gu	Changes of biomarkers in a MSM HIV infection indicate the requirements of both antigen and antibody tests for early diagnosis	P07.17	STI/HIV diagnosis
Max Chernesky	Ease, Comfort and Performance of a Novel HerSwab Vaginal Self-sampling Device for the Detection of C. trachomatis and N. gonorrhoeae	P07.18	STI/HIV diagnosis
Celine Langendorf	Added Value of a Novel Dual Treponemal/Non-Treponemal Rapid Diagnostic Test For Syphilis among Pregnant Women	P07.19	STI/HIV diagnosis
Claire Bristow	Field Evaluation of a Dual Rapid Diagnostic Test for HIV infection and Syphilis in Port-au-Prince, Haiti	P07.20	STI/HIV diagnosis
Claire Bristow	Serum cytokine analysis among patients with and without early syphilis infection	P07.21	STI/HIV diagnosis
John Osiecki	Performance Characteristics of an Automated Assay on the Cobas® 4800 System to Detect Herpes Simplex Virus from Genital Lesion Specimens with the Cobas® HSV 1 and 2 Test	P07.22	STI/HIV diagnosis
John Osiecki	Evaluation of the cobas® HSV 1 and 2 Test for the detection of HSV from clinician-collected anogenital lesion swab specimens compared with ELVIS® HSV ID and D³ Typing Test and Sanger Sequencing	P07.23	STI/HIV diagnosis
John Osiecki	Predicted Inclusivity and Specificity of The Cobas® 4800 CT/NG Test Through Global Surveillance Monitoring	P07.24	STI/HIV diagnosis
John Osiecki	Comparison of cobas® HSV 1/2 Test, Quidel Lyraâ„¢ Direct HSV 1+2/VZV, BD ProbeTecTM HSV 1/2 Qx Assay and Sanger Sequencing Using Clinician-collected Anogenital Lesion Swabs	P07.25	STI/HIV diagnosis
Tania Sadlon	Evaluation of a Novel Transcription Mediated Amplification Assay for the Detection of Herpes Simplex Virus from Clinical Samples	P07.26	STI/HIV diagnosis
Terri Warren	Performance of HerpeSelect ELISA for diagnosis of HSV-1 and HSV-2 infection in a clinical setting	P07.27	STI/HIV diagnosis
Mary Louise Kamb	Syphilis testing in antenatal care: policies and practices among laboratories in the Americas	P07.28	STI/HIV diagnosis
Michael O'Reilly	Point of Care Testing (POCT) for HIV; can venipuncture be avoided for Syphilis?	P07.29	STI/HIV diagnosis
Xiaojun Meng	Impact of expanded screening on the detection of HIV and syphilis in Wuxi, China	P07.30	STI/HIV diagnosis
Stephen Jordan	Characterizing CD4+ and CD8+ T-Cell Responses by Intracellular Cytokine Staining in Women with and without Chlamydia Trachomatis Reinfection	P08.01	Chlamydia infections
Bronwyn Joubert	Chlamydia trachomatis causes mitochondrial damage in keratinocytes	P08.02	Chlamydia infections
Prashant Mishra	Mining Genome of Chlamydia Trachomatis to Identify Vaccine Candidates	P08.03	Chlamydia infections
Dorothy Patton	Pathogenicity of plasmid positive and negative Chlamydia trachomatis in a macaque model of ocular and genital tract diseases	P08.04	Chlamydia infections
Dorothy Patton	Chlamydia trachomatis and Trichomonas vaginalis co-infection in the macaque model	P08.05	Chlamydia infections
Jacques Ravel	Lactic Acid Isomers Differentially Reduce Chlamydia Trachomatis Infection in a Ph Dependent Manner	P08.06	Chlamydia infections
Yvonne Sweeney	Chlamydia trachomatis cervical infection / rectal detection in the macaque model	P08.07	Chlamydia infections
Yvonne Sweeney	Expanding the macaque model of Trichomonas vaginalis infection	P08.08	Chlamydia infections
Joanne Reekie	Trends in chlamydia and gonorrhoea testing and positivity in Western Australian women, 1998-2013	P08.09	Chlamydia infections
Antoinette Righarts	Chlamydia Trachomatis Infection in Samoan Women: Prevalence and Risk Factors	P08.10	Chlamydia infections
Antoinette Righarts	Chlamydia trachomatis incidence from self-reports and serology by gender, age-period, and partner numbers in a birth cohort	P08.11	Chlamydia infections
Sarah Woodhall	Insights into Chlamydia trachomatis cumulative incidence in the context of widespread opportunistic chlamydia screening in England: Seroprevalence study using sera from a nationally-representative household survey	P08.12	Chlamydia infections
Sarah Woodhall	What can probability surveys tell us about changes in chlamydia prevalence in Britain? Evidence from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)	P08.13	Chlamydia infections
Helena Krutáková	Lymphogranuloma Venereum in The Czech Republic	P08.14	Chlamydia infections
Ruth Verbrugge	Increasing number of lymphogranuloma venereum cases in Belgium: overview 2011-2014	P08.15	Chlamydia infections
Ruth Verbrugge	Risk profile of patients diagnosed with a sexually transmitted infection (STI) : a comparison of patients consulting general practices (GP) and specialised sexual health clinics (SHC) in Belgium, 2013-2014	P08.16	Chlamydia infections
William Geisler	Influence of Chlamydia trachomatis organism load on reinfection risk	P08.17	Chlamydia infections
Jane Goller	Regional Variation in Emergency Department Presentation Rates of Chlamydia Related Morbidity in Australia	P08.18	Chlamydia infections
Jane Goller	Risk of Pelvic Inflammatory Disease from Chlamydia and Gonorrhoea among Australian Sexual Health Clinic Attendees	P08.19	Chlamydia infections
Jane Goller	Pathogen Negative Pelvic Inflammatory Disease: Is it PID?	P08.20	Chlamydia infections
Nicola Low	Sex and Pelvic Inflammatory Disease: What’s The Relationship? Case-Control Study	P08.21	Chlamydia infections
Nicola Low	How High is High Risk? Sexual Behaviour and Chlamydia Infections in Women Attending Genitourinary Medicine Clinics	P08.22	Chlamydia infections
Shruti Menon	Sero-Epidemiological Assessment Indicates High Prevalence of C. Trachomatis in Samoan Women with Infertility	P08.23	Chlamydia infections
Malcolm Price	Alternative Evidence Sources Present A Consistent Picture of the Population Excess Fraction (PEF) of Pelvic Inflammatory Disease Caused by Chlamydia Trachomatis Infection in England.	P08.24	Chlamydia infections
Rachel Gorwitz	Tubal factor infertility (TFI) epidemiology in infertility clinic patients	P08.25	Chlamydia infections
Rebecca Lorch	The impact of education on Australian practice nurses’ knowledge and attitudes in relation to chlamydia testing: findings from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt)	P08.26	Chlamydia infections
Alannah Priddle	Results of a 2014 QLD trial of pharmacy accessed testing for Chlamydia trachomatis via retail self-test uri swab postal specimen kits	P08.27	Chlamydia infections
Emma Harding-Esch	Patients continue to engage in risky sexual behaviour in the time period between being tested for Chlamydia and receiving test result and treatment	P08.28	chlamydia infections
Emma Harding-Esch	Web-tool to assess the cost-effectiveness of chlamydia point-of-care tests at the local level	P08.29	Chlamydia infections
Jane Hocking	Chlamydia tests ordered, but not undertaken: socio-demographic and structural barriers in general practice	P08.30	Chlamydia infections
Clarissa Moreira	Screening for Chlamydia Concurrently with a Routine Pap Test in Primary Care: Could Cervical Screening Changes Impact on Chlamydia Testing?	P08.31	Chlamydia infections
Rendry Del Rosario	The Feasibility and Acceptability of Offering Opportunistic Chlamydia Screening in a Nurse-Led Primary Health Care Clinic	P08.32	Chlamydia infections
Fabian Kong	Azithromycin pharmacokinetics and implications for extended doses for Chlamydia trachomatis	P08.33	Chlamydia infections
Christian Althaus	Number of Sex Acts Matters for Heterosexual Transmission and Control of Chlamydia Trachomatis	P08.34	Chlamydia infections
Bart Versteeg	Cluster Analysis of Chlamydia Trachomatis Strains Using Two Multilocus Sequence Typing Schemes Shows Differences in Discrimination of MSM Strains Versus Those Of Heterosexuals	P08.35	Chlamydia infections
Klaus Jansen	Chlamydia trachomatis infection in women in Germany, 2008-2014	P08.36	Chlamydia infections
Katy Turner	Epidemiological trends in chlamydia testing in Denmark 1991 To 2011: the Danish Chlamydia Study	P08.37	Chlamydia infections
Katy Turner	Cost-effectiveness of genital chlamydia testing in Scotland	P08.38	Chlamydia infections
Katy Turner	Cost-Effectiveness of Testing for Trichomonas vaginalis in genitourinary medicine clinics and primary care in England using Aptima TV NAAT	P09.01	Bacterial and other curable STI
Patrick Horner	Reattendance rates in men presenting with symptoms of urethritis - Can point of care testing for chlamydia and gonorrhoea improve outcomes?	P09.02	Bacterial and other curable STI
Patrick Horner	Treatment of Mycoplasma genitalium with azithromycin 1 g is less efficacious and associated with induction of macrolide resistance compared to a 5 day regimen	P09.03	Bacterial and other curable STI
Charlotte van der Veer	Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, The Netherlands	P09.04	Bacterial and otehr curable STI
Yan Han	Unusually low prevalence of Mycoplasma genitalium and Trichomonas vaginalis in urine samples from Chinese women attending a center of prenatal diagnosis	P09.05	Bacterial and other curable STI
Klaus Jansen	High prevalence of genital infections with Mycoplasma genitalium in female sex workers reached at their working place in Germany: the STI-Outreach study	P09.06	Bacterial and other curable STI
Klaus Jansen	Prevalence of Mycoplasma Genitalium in Patients Visiting HIV Counselling Institutions in North-Rhine-Westphalia, Germany (STI-HIT Study)	P09.07	Bacterial and other curable STI
Klaus Jansen	Strong and ongoing increase of syphilis in MSM in Germany	P09.08	Bacterial and other curable STI
Ben Hui	Exploring the relationship between importation frequency and the persistence of gonorrhoea strains in an MSM population: a modelling study	P09.09	Bacterial and other curable STI
Kate Seib	The potential impact of vaccination on the prevalence of gonorrhea	P09.10	Bacterial and other curable STI
Peter White	Should we Screen for Mycoplasma Genitalium? Evidence Synthesis using a Transmission-Dynamic Model	P09.11	Bacterial and other curable STI
Peter White	Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma Genitalium Are Consistent after Accounting for Incidence of (Re) Infection and Study Design	P09.12	Bacterial and other curable STI
Peter White	Impact and Cost-Effectiveness of Point-Of-Care Testing for Chlamydia: Accounting for Geographic Variation in Infection Burden and Testing Rates, Health Service Configuration, and Implementation Strategy	P09.13	Bacterial and other curable STI
Laura Bachmann	Implementation of Oral and Self-Collected Rectal Swabs for N. gonorrhoeae and C. Trachomatis Detection as a Component of Local Health Department Outreach Testing	P09.14	Bacterial and other curable STI
Trang Nguyen	Time to Clearance for Molecular Test-Of-Cure among Men Treated for Urethral, Pharyngeal, or Rectal Gonorrhea in San Francisco, 2013-2014	P09.15	Bacterial and other curable STI
Stephanie Taylor	Isolation of Neisseria Meningitidis during a Gonorrhea Treatment Trial	P09.16	Bacterial and other curable STI
Guoyu Tao	Rectal Infection with N. Gonorrheae and C. Trachomatis in Men in the United States	P09.17	Bacterial and other curable STI
Guoyu Tao	Suboptimal Prenatal Testing for Syphilis and Other STDs among Commercially-insured Women in the United States, 2013	P09.18	Bacterial and other curable STI
Kathleen Ryan	Results from a Prevalence Study of Neisseria Gonorrhea and Chlamydia Trachomatis in a Community Based, Peer led HIV Testing Service	P09.19	Bacterial and other curable STI
Amina Hancali	Trend of STIs prevalence among women and men in Morocco between 1999 to 2011	P09.20	Bacterial and other curable STI
Kees Rietmeijer	Performance of GeneXpert® in the Diagnosis of Neisseria gonorrhoeae and Chlamydia Trachomatis among Men and Women with Genital Discharge Syndrome in Zimbabwe	P09.21	Bacterial and other curable STI
Kees Rietmeijer	The Aetiology of Genital Discharge Syndromes in Zimbabwe	P09.22	Bacterial and other curable STI
Kees Rietmeijer	High Prevalence of HIV Infection among Patients with STI Syndromes in Zimbabwe: Implications for Prevention	P09.23	Bacterial and other curable STI
Kees Rietmeijer	The Aetiology of Genital Ulcer Disease and Association with HIV Infection in Zimbabwe	P09.24	Bacterial and other curable STI
Eric Chow	Duration of syphilis symptoms at presentations in men who have sex with men in Australia: are current public health campaigns effective?	P09.25	Bacterial and other curable STI
Eric Chow	Trends in gonorrhoea positivity by nucleic acid amplification testing versus culture in heterosexual men in Victoria, Australia, 2007-2014.	P09.26	Bacterial and other curable STI
Xiangdong Gong	Epidemiology of Gonorrhea in China from 2000 to 2014	P09.27	Bacterial and other curable STI
Xiangdong Gong	Survey on the Data Quality of Syphilis Cases Reported in 5 Provinces Of China in 2013	P09.28	Bacterial and other curable STI
Hilary Reno	High prevalence of Neisseria gonorrhoeae among emergency department "superusers" in a large urban medical center	P09.29	Bacterial and other curable STI
Paula Badran	Temporal Distribution of Syphilis Serological Tests (VDRL) Demand and Positivity in a Reference Municipal Central Laboratory: Is There Increase After Carnival?	P09.30	Bacterial and other curable STI
Cremildo Baptista	Factors Associated with Syphilis Seroreactivity among Polydrug Users in Northeast Brazil: A Cross-Sectional Study Using Respondent Driven Sampling	P09.31	Bacterial and other curable STI
Cremildo Baptista	Correlates of HIV Testing among Polysubstance Users in 10 Brazilian Cities: A Respondent Driven Sampling Survey	P09.32	Bacterial and other curable STI
Cremildo Baptista	Sexual Behaviors and Unprotected Sex with Casual and Commercial Partners among Polysubstance Users in Brazil: Findings from a Respondent Driven Sampling Study	P09.33	Bacterial and other curable STI
Antonio Flores	Molecular identification of treponema pallidum strains from syphilitic lesions in STI clinic patients, Lima, Peru.	P09.34	Bacterial and other curable STI
Linda Garton	Eradication of syphilis? - Not there yet. Ongoing public health response to a syphilis outbreak in the Northern Territory, Australia	P09.35	Bacterial and other curable STI
Freddy Perez	Improving uptake, interpretation and quality of syphilis testing in the Americas through the development of a new regional guidance document	P09.36	Bacterial and other curable STI
Sonia Morales-Miranda	Syphilis Rapid Test Validation for Treponemal Diagnosis in Guatemala, 2013-2014.	P09.37	Bacterial and other curable STI
Sonia Morales-Miranda	Syphilis Prevalence and Risk Behavior among People Living with HIV in Managua, Nicaragua: BSS-2009, BSS-2014 and STI Sentinel Surveillance (VICITS) 2014.	P09.38	Bacterial and other curable STI
Sonia Morales-Miranda	HIV/Syphilis Prevalence and Risk Behaviors among Transgender Women and Men Who Have Sex with Men in Nicaragua: Sentinel Surveillance and STI Control (VICITS), 2014.	P09.39	Bacterial and other curable STI
Hannah Shull	Prevalence of curable sexually transmitted infections in pregnant women in low- and middle-income countries: A systematic review	P09.40	Bacterial and other curable STI
Angelica Espinosa Miranda	Chlamydia trachomatis screening among preterm births in Brazil: An experience from a University Hospital	P09.41	Bacterial and other curable STI
Johnson Katanga	screening for syphilis, hiv and haemoglobin during pregnancy in moshi municipality,Tanzania: how is the the health system performing?	P09.42	Bacterial and other curable STI
Samsiya Ona	Sexually transmitted infection screening and follow-up in a high-risk urban obstetric clinic	P09.43	Bacterial and other curable STI
Jose Eleuterio Jr	High-risk HPV is a marker for atypical intraanal cytology in immunocompetent women	P10.01	Human papillomavirus infections and other viral STI
Andrew Vallely	Field evaluation of the Xpert HPV Test for the detection of human papillomavirus infection in women using self-collected vaginal compared to clinician-collected cervical specimens	P10.02	Human papillomavirus infections and other viral STI
Iskandar AzwaI	Anal human papillomavirus (HPV) infection and anal intraepithelial neoplasia (AIN) among men who have sex with men (MSM) in Kuala Lumpur, Malaysia	P10.03	Human papillomavirus infections and other viral STI
Julian Langton-Lockton	A new paradigm for follow-up of men with Anal Squamous Cell Cancer (ASCC)	P10.04	Human papillomavirus infections and other viral STI
Jason Ong	Is it cost-effective to screen for anal cancer? Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV	P10.05	Human papillomavirus infections and other viral STI
Deepti Bajpai	Prognostic importance of DNA repair gene polymorphisms in cervical cancer patients from India	P10.06	Human papillomavirus infections and other viral STI
Fernanda Carestiato	Mapping the integration sites E1-E2 of HPV-16 and HPV-18 as a tool to evaluate different stages of cervical disease progression	P10.07	Human papillomavirus infections and other viral STI
Elaine Flagg	Prevalence of Low- and High-Grade Cervical Intraepithelial Lesions Among Female Participants in Private Health Plans in the United States, 2007-2013: Ecologic Evidence of Population Effectiveness of Human Papillomavirus Vaccination	P10.08	Human papillomavirus infections and other viral STI
Xiaojun Meng	View on human papillomavirus vaccination among at-risk men in Wuxi, China: a cross-sectional study	P10.09	Human papillomavirus infections and other viral STI
Winnie Tong	T-cells in the anal mucosa of men with HSIL	P10.10	Human papillomavirus infections and other viral STI
Huachun Zou	Serum Antibody Responses Following Anal and Penile Infection with Human Papillomavirus in Teenage Men who have Sex with Men	P10.11	Human papillomavirus infections and other viral STI
Huachun Zou	Role of Condyloma Acuminata in Incident HIV Infection: A Population-Based Cohort Study in Taiwan 2000-2010	P10.12	Human papillomavirus infections and other viral STI
Mary Poynten	Prevalence and predictors of high-risk anal human papillomavirus (HPV) types in the study of the prevention of anal cancer (SPANC)	P10.13	Human papillomavirus infections and other viral STI
Pannarat Pensuk	Factors associated with HPV vaccination coverage at school level during HPV vaccine introduction in Thailand	P10.14	Human papillomavirus infections and other viral STI
Sarwat Mahmud	The epidemiology of hepatitis C virus in Afghanistan: Systematic review and meta-analysis	P10.15	Human papillomavirus infections and other viral STI
Latesha Elopre	Factors Associated With Acceptance of Genital Herpes Testing for Black Patients Presenting for Care at an STD Clinic	P10.16	Human papillomavirus infections and other viral STI
Su Airong	Inhibition of Herpes Simplex Virus 1 (HSV-1) Replication by Inositol-Requiring Enzyme 1 (IRE1) Pathway	P10.17	Human papillomavirus infections and other viral STI
Kaushal Verma	Acyclovir 1 gm Twice a Day for 3 days for the Treatment of Recurrent Genital Herpes	P10.18	Human papillomavirus infections and other viral STI
Sarah Woodhall	Can HSV-2 seropositivity be used as a biological marker of sexual behaviour? Findings from a seroprevalence survey in England	P10.19	Human papillomavirus infections and other viral STI
David Yurick	Digital Droplet PCR (DDPCR) Quantification of Human T-Lymphotropic Virus Type-1 Clade C in Peripheral Blood and Lung Infiltrates of Indigenous Australian Bronchiectasis Patients	P10.20	Human papillomavirus infections and other viral STI
Neerja Puri	a study on the use of imiquimod for the treatment of genital  molluscum contagiosum and genital warts in female patients	P10.21	Human papillomavirus infections and other viral STI
Khamis Tomusange	Engineering human rhinovirus serotype-A1 as a vaccine vector	P10.22	Human papillomavirus infections and other viral STI
Nigel Dickson	Same-sex behaviour and experience measured on multiple occasions in a birth cohort reveals higher lifetime prevalence than would be found in a cross-sectional study	P11.01	Sexual behaviour and STI in men who have sex with men and transgender people
Philip Prah	Representing men who have sex with men (MSM) in Britain: Evidence from comparative analyses of the latest convenience and probability surveys	P11.02	Sexual behaviour and STI in men who have sex with men and transgender people
Abigail Norris Turner	Lubricant Use during Receptive Anal Intercourse and Rectal Chlamydial and Gonococcal Infections among Men who Have Sex with Men	P11.03	Sexual behaviour and STI in men who have sex with men and transgender people
Christine Khosropour	Proportion of HIV and Sexually Transmitted Infection (STI) Cases among Men Who Have Sex with Men (MSM) Attributable to Serosorting	P11.05	Sexual behaviour and STI in men who have sex with men and transgender people
Abigail Norris Turner	The Spectrum of Sexual Behaviors Among MSM And Associations with Prevalent Sexually Transmitted Infections and HIV	P11.07	Sexual behaviour and STI in men who have sex with men and transgender people
Charles Salil	Knowledge of sexually transmitted disease risk among men who have sex with men	P11.08	Sexual behaviour and STI in men who have sex with men and transgender people
Ricardo Mendizabal-Burastero	STI Prevention in Public Health Services for Transgender Women in Guatemala	P11.09	Sexual behaviour and STI in men who have sex with men and transgender people
Ricardo Mendizabal-Burastero	Anal and Oropharyngeal STI Surveillance among Men Who Have Sex with Men in Guatemala	P11.10	Sexual behaviour and STI in men who have sex with men and transgender people
David Leitinger	High Rates of Co-Occurring Sexually Transmissible Infections among Men who have Sex with Men attending High-Caseload General Practice and Sexual Health Services in Victoria	P11.11	Sexual behaviour and STI in men who have sex with men and transgender people
Claire Danby	Pharyngeal Neisseria Gonorrhoeae and Chlamydia Trachomatis in Men and Women with a History of Receptive Oral and Anal Intercourse	P11.12	Sexual behaviour and STI in men who have sex with men and transgender people
Jeanne Cabeza	Extra-Genital and Urethral Chlamydia Trachomatis and Neisseria Gonorrheae Prevalence and Associated Risk Factors in Men who have Sex with Men and Transgender Women in Lima, Peru	P11.13	Sexual behaviour and STI in men who have sex with men and transgender people
Sian Goddard	Pharyngeal and Anogenital Chlamydia in Men Who Have Sex with Men: Temporal Trends and Characteristics among Attendees at a Sydney Metropolitan Sexual Health Clinic 2011-2014	P11.14	Sexual behaviour and STI in men who have sex with men and transgender people
Sarika Pattanasin	Factors associated with repeat symptomatic gonorrhea infections among men who have sex with men, bangkok, thailand	P11.15	Sexual behaviour and STI in men who have sex with men and transgender people
Mark Stenger	Denominators Matter: Trends in Neisseria gonorrhoeae Incidence among Gay, Bisexual and other Men Who Have Sex with Men (GBMSM) in the U.S. – Findings from the STD Surveillance Network (SSuN) 2010 – 2013	P11.16	Sexual behaviour and STI in men who have sex with men and transgender people
Nigel Field	Intensification of a shigellosis epidemic associated with sexual transmission between men: diagnoses of Shigella flexneri and S. sonnei in England, 2004 to 2015	P11.17	Sexual behaviour and STI in men who have sex with men and transgender people
Vicente Aleixandre Benites-Zapata	Relationship between Anal Sex Behaviors and Incident Syphilis Infection among MSM And Transgender Women from Two Clinics in Lima Peru	P11.18	Sexual behaviour and STI in men who have sex with men and transgender people
Chaiwat Ungsedhapand	Syphilis incidence and associated risk factors among men who have sex with men in Bangkok, Thailand, 2006-2015	P11.19	Sexual behaviour and STI in men who have sex with men and transgender people
Fleur van Aar	Resurgence of syphilis among HIV-infected men who have sex with men attending STI clinics in the Netherlands	P11.20	Sexual behaviour and STI in men who have sex with men and transgender people
Maria Herrera	Characterizing the Epidemiology of Active Hepatitis B Virus Infection among High-Risk Men Who Have Sex with Men and Transgender Women in Lima, Peru	P11.21	Sexual behaviour and STI in men who have sex with men and transgender people
Maria Herrera	Hepatitis C Infections among High-Risk Men Who Have Sex with Men and Transgender Women in Lima, Peru	P11.22	Sexual behaviour and STI in men who have sex with men and transgender people
Andrew Foster	Evaluation of Hepatitis C Virus in the Rectum of HIV-Infected Men who have Sex with Men	P11.23	Sexual behaviour and STI in men who have sex with men and transgender people
Hicham Oumzil	Landscape of HSV2 and HIV Infections among MSMS in Morocco: Results from a Respondent Driven Sampling Survey	P11.24	Sexual behaviour and STI in men who have sex with men and transgender people
Hayden Jose	Timor-Leste National Size Estimates and Behavioural Data for Key Populations at Risk of HIV and Other STIs	P11.25	Sexual behaviour and STI in men who have sex with men and transgender people
Hayden Jose	The Social and Sexual Dynamic between Gay Men/Transgender People and Their Straight-Identifying Male Partners in Timor-Leste	P11.26	Sexual behaviour and STI in men who have sex with men and transgender people
Anna Wilkinson	Does Accessing Non-Occupational Post Exposure Prophylaxis And The Associated Clinical Experience Impact Condom Use Among Men Who Have Sex With Men In Victoria, Australia.	P11.27	HIV testing, treatment and care
Jeffrey Dabbhadatta	'Gay Friendly GP' Online Training: Strengthening capacity of primary care in working with gay men and men who have sex with men patients	P11.28	Sexual behaviour and STI in men who have sex with men and transgender people
Bradley Stoner	Using Qualitative Research Methods to Elucidate "Emic" Constructions of Risk and Seroadaptive Behaviors among Men who have Sex with Men (MSM)	P11.29	Sexual behaviour and STI in men who have sex with men and transgender people
Budi Sudarto	Out Later in Life: Working with Older Same-Sex Attracted Men	P11.30	Sexual behaviour and STI in men who have sex with men and transgender people
Duong Thanh	HIV/STI Prevalence, Sexual Risk, and Drug Use Among Men Who Have Sex With Men in Urban Settings in Vietnam	P11.31	Sexual behaviour and STI in men who have sex with men and transgender people
Eline Op de Coul	Socio-Demographic and Behavioural Characteristics of Men Who Have Sex With Men (MSM) in The Netherlands Who Have Never Been Tested for HIV	P11.32	Sexual behaviour and STI in men who have sex with men and transgender people
Claudia Estcourt	Getting your Chlamydia Care Online: Qualitative Study among users of the Chlamydia Online Clinical Care Pathway (Chlamydia-OCCP), in Proof of Concept Study	P12.01	STI care
Jo Gibbs	Developing and Using the Eclinical Care Pathway Framework: A Novel Tool for Creating Online Clinical Care Pathways and Its Application to Management of Genital Chlamydia	P12.02	STI care
Jo Gibbs	How Accurate and Comprehensive are Currently Available Mobile Medical Applications (Apps) for Sexually Transmitted and Genital Infections: A Comprehensive Review	P12.03	STI care
Karen Rogstad	The Evidence for Sexually Transmitted infections as a marker for Child Sexual Abuse: The Physical signs of child sexual abuse 2nd edition 2015	P12.04	STI care
Donna Tilley	Outreach chlamydia testing: upskilling a multidisciplinary workforce	P12.05	STI care
Donna Tilley	Genital Trichomonas Vaginalis is Rare Among Female Attendees at a Sydney Metropolitan Sexual Health Clinic	P12.06	STI care
Daniel McCartney	Delivering Increased Service Provision: IPPF Experience of Providing Targeted Technical Support within Existing SRH Service Delivery Points for Strengthened STI-Specific Service Provision	P12.07	STI care
Daniel McCartney	STI Management is HIV Prevention: Improving Access to a Comprehensive Package of Stigma-Free SRH and HIV Services for Key Populations by Implementing the Latest WHO Guidelines	P12.08	STI care
Hannelore Götz	HIV Cascade of Care: Improvements in Linkage to Care at the STI Clinic of the Public Health Service Rotterdam-Rijnmond	P12.09	STI care
Hannelore Götz	Challenges in implementing a partner notification webtool in GP practices in the Netherlands: preliminary results of a pilot study	P12.10	STI care
Hannelore Götz	Reach of STI clinics by high-risk ethnic groups in the Netherlands	P12.11	STI care
Thomas Agyarko-Poku	Bacteria Aetiology of Sexually Transmitted Infections at Sexually Transmitted Infection Clinic in Kumasi, Ghana; Use of Multiplex Real Time Polymerase Chain Reaction.	P12.12	STI care
Thomas Agyarko-Poku	Integrating Sexually Transmitted Infections (STI) Intervention Project for Female Sex Workers (FSW) into Primary Level of Care in Ghana:  Assessing The Impact A Decade After Project Implementation.	P12.13	STI care
Janet Towns	Clinical Descriptions of PCR Positive Early Syphilis Infections	P12.14	STI care
Somesh Gupta	Penile Papulonecrotic Tuberculosis: Is it a Sexually Transmitted Disease?	P12.15	STI care
Susan Tuddenham	Older patients attending sexually transmitted infections clinics	P12.16	STI care
Anne Robertson	Should Specialist Sexual Health Services Still See Self-Referrals	P12.17	STI care
Chiyo Morton	Sexual and Reproductive Health in Rural Victoria: What Urgent Care Services are Available and are they Adequate?	P12.18	STI care
Rod Nixon	Towards Universal Access: The Papua New Guinea (Png) Companion Product Condom Distribution Trial	P13.01	Operational and health systems research
Magdalena Simonis	Female Genital Cosmetic Surgery Toolkit for General Practitioners and Other Health Professionals	P13.02	Operational and health systems research
Phillip Read	Targeted Primary Health Care and Sexual Health Services can deliver the Hepatitis C Strategy: One year of Fibroscans at the Kirketon Road Centre (KRC)	P13.03	Operational and health systems research
Lisa Natoli	"I Do Feel Like a Scientist at Time Yeah…" Acceptability of Point-Of-Care Testing for Chlamydia and Gonorrhea to Health Service Providers in Remote Primary Care	P13.04	Operational and health systems research
Dadong Wu	Prevention of Mother-To-Child Transmission of Syphilis and HIV in China: What Drives Political Prioritization and what can this tell us about Promoting Dual Control?	P13.05	Operational and health systems research
Barbara Nattabi	Knowledge translation: development of a sexual health clinical audit tool to enhance adherence to evidence-based guidelines	P13.06	Operational and health systems research
Leigh Chislett	Which elements of a novel self-directed rapid asymptomatic sexually transmitted infection screening service are most important to users?	P13.07	Operational and health systems research
Maureen Todkill	ACT Testing Month: promoting testing and increasing cross sector collaboration	P13.08	Operational and health systems research
Katy Town	Evaluation of a Pilot to Improve Primary Care Sexual Health Services in England: Analysis of Chlamydia Testing and Diagnosis Rate Changes	P13.09	Operational and health systems research
Janet Wilson	Club Drug Use, Sexual Behaviour and STI Prevalence in Sexual Health Clinic Attendees in a UK City	P13.10	Operational and health systems research
Janet Wilson	Self-taken extragenital sampling for chlamydia and gonorrhoea in women - is it acceptable? Feedback from a self-swab and clinician-swab trial	P13.11	Operational and health systems research
Prithika Prasad	HIV Sensitisation Health Care Worker Training in Vanuatu	P13.12	Operational and health systems research
Eline Op de Coul	Sexually transmitted infection Care in termination of pregnancy clinics in the Netherlands	P13.13	Operational and health systems research
Gemma Sharp	Educating Women about Normal Female Genital Appearance: The Effectiveness of Two Brief Interventions	P13.14	Operational and health systems research
Alaina Vaisey	Is knowledge power? Associations between chlamydia knowledge and sexual practices in young Australian adults: findings from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt)	P14.01	Social sciences, policy and programmes
Nathan Kuk	Systematic Review: Does a positive human papillomavirus vaccination status increase the risk of unsafe sexual health practice?	P14.02	Social sciences, policy and programmes
Rochelle Hamilton	Chronic Vulval Pain/Vulvodynia? ?Psychosexual Issues? Taking a Different Approach	P14.03	Social sciences, policy and programmes
Jackie Cassell	Which psychosocial factors are associated with poor sexual health outcomes in women of reproductive age?  A systematic review of probability surveys.	P14.04	Social sciences, policy and programmes
Jade Bilardi	Sexual contact is the trigger! Women's views and experience of the causes and triggers of bacterial vaginosis	P14.05	Social sciences, policy and programmes
Roxanne Beauclair	Characterizing concurrent partnerships in Cape Town, South Africa	P14.06	Social sciences, policy and programmes
Viv McGregor	Sexual Health Promotion and STI Prevention on the Margins: Kink, BDSM, and Sexually Adventurous Women	P14.07	Social sciences, policy and programmes
Ankita Siddhanta	Comparative study of vulnerability of circumcision among women of Kenya and Nigeria	P14.08	Social sciences, policy and programmes
Edwin Bernard	Advancing HIV and STI Justice: The Key Role of Science and Scientists in Ending Overly Broad HIV and STI Criminalisation	P14.09	Social sciences, policy and programmes
Dion Nuryadi	Fight for the right to health care services for people with HIV	P14.10	Social sciences, policy and programmes
Shailendra Sawleshwarkar	Developing Sustainable, International Partnerships Model to Build Capacity in HIV and STIs	P14.11	Social sciences, policy and programmes
Deb Welsby	Collaboration is the New Black: Developing the NSW Sexual Health Promotion Framework	P14.12	Social sciences, policy and programmes
Shari Krishnaratne	HIV-Related Stigma And Universal Testing And Treatment For HIV Prevention And Care: Design Of An Implementation Science Evaluation Nested In The HPTN 071 (Popart) Cluster-Randomised Trial In Zambia And South Africa	P14.13	Social sciences, policy and programmes
Shari Krishnaratne	Intersecting Stigmas: A Framework for Data Collection and Analysis of Stigmas Faced by People Living With HIV and Key Populations	P14.14	Social sciences, policy and programmes
Joey Joleen Mataele	In the system (Tongan Society) but out of sight.	P14.15	Social sciences, policy and programmes
Aldora Robinson	Self Reported HIV Discrimination and Willingness to Disclose HIV Seropositivity among a Sample of Turks and Caicos Islanders.	P14.16	Social sciences, policy and programmes
Vivian Black	Surveillance for Sexually Transmitted Infections among Female Sex Workers in Inner-City Johannesburg.	P14.17	Social sciences, policy and programmes
Georges Batona	UNDERSTANDING THE INTENTION TO UNDERGO REGULAR HIV TESTING AMONG FEMALE SEX WORKERS IN BENIN: A KEY ISSUE FOR ENTRY INTO HIV CARE	P14.18	Social sciences, policy and programmes
Clare Bellhouse	The impact of sex work on women's personal romantic relationships	P14.19	Social sciences, policy and programmes
Dee-Amela Conti	Relationship myth between Sex Workers, STI's and  HIV	P14.20	Social sciences, policy and programmes
Floribert MONGA LISANGI	The impact of the IEC (information, education and communication) in the affidavit of sex workers Study realized by the youth center Coulibaly sidiki of the University of Kinshasa (Democratic Republic of Congo)	P14.21	Social sciences, policy and programmes
Tapas Kumar Saha	To prevent HIV/AIDS through awareness raising and social behaviors change of sex worker in bangladesh.- an experience from kandapara brothel, tangail, bangladesh.	P14.22	Social sciences, policy and programmes
Obert Samba	Transgender Sex Workers Response to HIV in Papua New Guinea	P14.23	Social sciences, policy and programmes
Caroline Thng	Multicultural Survey - Asian Female Sex Worker Demographics, Migration and Sexual Health in Sydney	P14.24	Social sciences, policy and programmes
Denton Callander	HIV and STIs among male sex workers attending Australian sexual health clinics	P14.25	Social sciences, policy and programmes
kadek mulyawan	Analysis of risk factors incidence of sexually transmitted infections In the Women indirect sex workers in Mataram city,Indonesia. 2012	P14.26	Social sciences, policy and programmes
Tri Nguyen	Female sex workers (FSW) in Ba Ria - Vung Tau, Vietnam: socio-demographic characteristics and risk behaviors	P14.27	Social sciences, policy and programmes
Tri Nguyen	Sexual Transmitted Infections and Risk Factors among female sex workers in Ba Ria - Vung Tau, Vietnam	P14.28	Social sciences, policy and programmes
Ngozi Otuonye	Establishment of Health Research Ethics and Capacity Building of Human Resources and Infrastructure in Nigeria	P14.29	Social sciences, policy and programmes
Lindsay Aboud	Innate mucosal serpin inhibits late stages of HIV life cycle and reduces cellular proliferation	P15.01	HIV basic sciences
Tahir Bashir	Human Hemoglobin derived peptide prevents HIV-1 infection and protects cells from HIV-1 induced inflammation	P15.02	HIV basic sciences
Funsho Ogunshola	Development of A New CEM Reporter T-Cells (GXR-Cells) Viral Inhibition Assay (VIA) For Elucidating The Role of Class-I-HLA Alleles on The Inhibitory Capacity Of HIV-1-Specific CD8+T-Cells	P15.03	HIV basic sciences
Smritee Dabee	Genital tract cellular activation and inflammation associated with highly prevalent sexually transmitted infections and bacterial vaginosis in adolescent women at risk for HIV infection	P15.04	HIV basic sciences
Philip Cunningham	Performance Evaluation of the Aptima HIV-1 Quant DS Assay for Detection of HIV-1 in Plasma and Dried Blood Spots (DBS)	P15.05	HIV basic sciences
Monray Edward Williams	Molecular Validation of Putative Antimicrobial Peptides for Improved Human Immunodeficiency Virus Diagnostics via HIV Protein P24	P15.06	HIV basic sciences
Yu-Hsiang Hsieh	An Agent-Based Model to Simulate and Predict HIV Epidemic in Baltimore City, Maryland, USA	P16.01	HIV epidemiology
King Tung Cheung	Predictors of HIV acquisition within 12 months of an HIV negative test in men who have sex with men	P16.02	HIV epidemiology
Gino M. Calvo	Comparison of Sexual Risk Behaviors among HIV Positive Men Who Have Sex with Men before and after their Diagnosis	P16.03	HIV epidemiology
Deepak Madi	Clinico-epidemiological profile of elderly HIV patients attending anti retro-viral therapy (ART) center of a teaching hospital in South India.	P16.04	HIV epidemiology
Olatunji Adetokunboh	Regional Epidemiological Pattern of  AIDS-Related Cancers in Children	P16.05	HIV epidemiology
kiplagat charles	Knowledge of Kaposi Sarcoma (KS) among HIV + Commercial Sex Workers on HIV Therapy in Kisumu Township, Kenya	P16.06	HIV epidemiology
Hua-Chun Zou	Prior Condyloma and Syphilis Diagnosis among HIV-Infected Persons: A Nationwide Population-Based Study in Taiwan, 2000-2010	P16.07	HIV epidemiology
sandra brunini	Prevalence of Sexually Transmitted Infections among Pregnant HIV-Positive in Central-West Brazil	P16.08	HIV epidemiology
Felicia Lewis	Coinfection with gonorrhea, syphilis or both does not appear to affect HIV transmission to the sexual contacts of HIV+ patients with undetectable viral loads.	P16.09	HIV epidemiology
Weiming Tang	Worsen Epidemic of Early HIV Infection among Men Who Have Sex with Men in China: Implication for Real Time Action	P16.10	HIV epidemiology
Annick Borquez	Estimating the Distribution of New HIV Infections by Key Determinants in Generalised Epidemics of Sub-Saharan Africa Using a Validated Mathematical Model	P16.11	HIV epidemiology
Sherrie Kelly	Optimization HIV Investment in Swaziland: Modelling High-Impact Interventions	P16.12	HIV epidemiology
Rakesh Singh	Epidemiology of HIV Prevalence among Urban Women in Tanzania	P16.13	HIV epidemiology
Herta De Oliveira Alexandre	Geography of AIDS in The State of Ceará, Brazil.	P16.14	HIV epidemiology
Herta De Oliveira Alexandre	Children and Young People Living with HIV/Aids in a State of Northeastern Brazil	P16.15	HIV epidemiology
Herta De Oliveira Alexandre	Aspects Related to the Quality of Life of Patients who use Antiretroviral Therapy	P16.16	HIV epidemiology
Yuneti Octavianus Nyoko	Correlation Between Demographics, Clinical And Risk Factor For HIV Infected With HIV/TB Co-Infected in Amertha Clinic Kerti Praja Foundation Bali	P16.17	HIV epidemiology
Yuneti Octavianus Nyoko	Influence of Baseline Characteristics on the Increase Cd4 >350 Cells/Mm3 Among HIV/AIDS Patients Receiving Antiretroviral Therapy in Indonesia	P16.18	HIV epidemiology
Elucir Gir	Nasal colonization with staphylococcus aureus in people living with hiv/aids after seven days of hospitalization	P16.19	HIV epidemiology
Elucir Gir	Bacterial Resistance of Staphylococcus Aureus Isolated from People Living with HIV/AIDS a Brazilian City	P16.20	HIV epidemiology
Elucir Gir	Women Sex Workers Living with HIV in a Capital of Northeastern Brazil - Preliminary Results	P16.21	HIV epidemiology
Elucir Gir	Prevalence and Epidemiology of Co-Infection HIV / Tuberculosis in a Brazilian City	P16.22	HIV epidemiology
Thiago Prado	Clinical and Epidemiological Characteristics Associated With Unfavorable Tuberculosis Treatment Outcomes In TB-HIV Co-Infected Patients In Brazil: A Hierarchical Polytomous Analysis	P16.23	HIV epidemiology
TAWATCHAI APIDECHKUL	A 20-Year Retrospective Cohort Study of TB Infection among the Hill Tribe HIV/AIDS Populations, Thailand	P16.24	HIV epidemiology
ku han chang	The Incidence and Associated Factors of Herpes Zoster among HIV Infected Patients: A Population-Based Retrospective Cohort Study in Taiwan, 2000 Through 2010	P16.25	HIV epidemiology
Dewa Pakshage Chula Kanishka Ananda Lal	Human Immunodeficiency Virus (HIV) - Mycobacterium Tuberculosis (TB) co-infection in Sri Lanka	P16.26	HIV epidemiology
Nazisa	Framingham chd and cvds risk equations in hiv and hiv/hcv population: a comparison study among malaysian hiv infected subjects on art	P16.27	HIV epidemiology
Nazisa Hejazi	Framingham coronary heart disease and cardiovascular risk assessments of hiv/aids malaysian population on haart: the importance of risks evaluations and predictions	P16.28	HIV epidemiology
Chia-yun Chung	Prevalence of Metabolic Risk Factors in HIV-Infected Population Under Antiretroviral Therapy in Northern Malawi.	P16.29	HIV epidemiology
Angelica Espinosa Miranda	Epidemiology of anal infection in HIV infected patients attending a Sexually Transmitted Infection Clinic in Brazil	P16.30	HIV epidemiology
Sonia Morales-Miranda	Improving Timely HIV Results in Key Populations: Rapid Test Antibody Evaluation For HIV Diagnosis in Guatemala, 2012-2013.	P16.31	HIV epidemiology
Leon McNally	Performance Evaluation of The Genexpert Hiv-1 Quant Assay For Detection of HIV-1 in Plasma	P17.01	HIV testing, treatment and care
Maria Jose Bustamante	Oraquick® In-Home HIV Test Kit in Peru: Availability and Acceptability among Men who have Sex with Men and Transgender Women	P17.02	HIV testing, treatment and care
Vickie Knight	Convenient HIV Testing Service Models Combined with Rapid Testing are Attracting Previously Untested Gay and Bisexual Men	P17.03	HIV testing, treatment and care
Silver Vargas	The Relationship between HIV Testing Frequency and HIV Risk Perception among Peruvian MSM and Transgender Women	P17.04	HIV testing, treatment and care
Hamish Mohammed	HIV test refusals among Black Africans attending sexually transmitted infection clinics in England, 2013	P17.05	HIV testing, treatment and care
Damian Jeremia Damian	HIV Prevalence and Factors Associated with HIV Testing among Young People (15 - 24 Years) in Tanzania:  A Secondary Analysis of This Data	P17.06	HIV testing, treatment and care
Rebecca Guy	Sexual Risk Behaviour Predicts More Frequent Use of HIV Self-Testing: Early Findings from the FORTH Trial	P17.07	HIV testing, treatment and care
Emily Huang	Using Grindr™, a Smartphone Social Networking Application, to Increase HIV Self-Testing among Men Who Have Sex with Men in Los Angeles	P17.08	HIV testing, treatment and care
Emily Huang	Cost-Effectiveness of HIV Self-Testing Promotion Through Grindrâ„¢, A Smartphone Social Networking Application	P17.09	HIV testing, treatment and care
Muhammad Jamil	HIV Testing Self-Efficacy is Associated with Higher HIV Testing Frequency and Perceived Likelihood to Self-Test Among Gay and Bisexual Men	P17.10	HIV testing, treatment and care
Muhammad Jamil	Public Sexual Health Clinics Increase Access, HIV Testing and Re-Testing Among Higher Risk Gay and Bisexual Men	P17.11	HIV testing, treatment and care
Adebayo Onajole	Providing evidence to support community based HCT screening programs - The voice of vulnerable rural youths in southwest Nigeria	P17.12	HIV testing, treatment and care
Komang Ayu Kartika Sari	Evaluating the Implementation of Couples HIV Counseling and Testing (CHCT) among Most at Risk Populations: An Experience from Bali, Indonesia	P17.13	HIV testing, treatment and care
Euphemia Sibanda	Barriers and Facilitators to Couples HIV Testing and Counselling And Views on Incentives for Couples Testing: A Qualitative Study from Zimbabwe	P17.14	HIV testing, treatment and care
Euphemia Sibanda	Barriers and Facilitators to Uptake of Cervical Cancer Screening among Clients Attending Integrated HIV/Sexual & Reproductive Health Clinics in Zimbabwe	P17.15	HIV testing, treatment and care
Katarzyna Bolsewicz	Personal Decisions around Anti-Retroviral Therapies (ART): Findings from The Literature and from a Qualitative Longitudinal Study with People Living with HIV (PLHIV) in Regional Queensland, Australia.	P17.16	HIV testing, treatment and care
Olukunle Omotoso	Using Effective Support Group Meetings to Improve and Sustain Support Group Membership: The Experiences and Outcomes of Support Groups in North-Central Nigeria	P17.17	HIV testing, treatment and care
Basavaprabhu Achappa	Factors Predicting the Occurrence of Tuberculosis Following Initiation of Highly Active Antiretroviral Therapy (HAART)	P17.18	HIV testing, treatment and care
Zachary Kwena	Time to Linkage, Retention and Adherence to HIV Care Among Married Couples in the Fishing Communities on Lake Victoria	P17.19	HIV testing, treatment and care
Helen Ward	Patient Perspectives on the HIV Treatment Cascade in The United Kingdom	P17.20	HIV testing, treatment and care
Edwin Machine	Failure to engage as key factor of loss to follow-up from care and treatment among HIV-infected children in Botswana: a case-control study	P17.21	HIV testing, treatment and care
Edwin Machine	Providers' perceptions of the causes of loss to follow-up of HIV-infected children in Botswana	P17.22	HIV testing, treatment and care
Christina Schumacher	Implementing Prioritized HIV Linkage-to-Care and Contact Tracing Among Individuals with High HIV Viral Load in Baltimore, Maryland, USA: Results from a Pilot Program	P17.23	HIV testing, treatment and care
Marianne van der Sande	Delayed linkage to care in a third of HIV positive individuals in the Netherlands: opportunities to improve the second step in the cascade of care.	P17.24	HIV testing, treatment and care
Yohane Gadama	Impact on Compliance with the Change of First Line Anti-Retroviral Drug Regimens Among Patients Attending Anteretroviral Therapy Clinics In Blantyre, Malawi	P17.25	HIV testing, treatment and care
Melanie Taylor	Viral loads among HIV-infected Persons diagnosed with Primary and	P17.26	HIV testing, treatment and care
Eloudiyi Houda	Decentralizing HIV Viral Load Testing to a Regional Laboratory in Agadir, Southern Morocco	P17.27	HIV testing, treatment and care
Eloudiyi Houda	Assessment of HIV-1 Primary Drug Resistance Mutations In Antiretroviral Therapy-Naive Cases In Morocco	P17.28	HIV testing, treatment and care
Hiroki Yagura	UGT1A1*6 Polymorphisms are Predictive of High Plasma Concentrations of Dolutegravir in Japanese Individuals	P17.29	HIV testing, treatment and care
Okeoma Mmeje	A Feasibility Study Assessing Fertility in HIV-Serodiscordant Couples Attempting Pregnancy in Kisumu, Kenya	P17.30	HIV testing, treatment and care
Okeoma Mmeje	Timed Vaginal Insemination as a Safer Conception Method for HIV-Serodiscordant Couples in Kisumu, Kenya	P17.31	HIV testing, treatment and care
Angela Satiti Retno Pudjiati	Risk Factors for Nevirapine-associated Rash and/or Hepatotoxicity among HIV-infected Patients in Indonesia	P17.32	HIV testing, treatment and care
Pakawadee Sriphiromya	Efavirenz-Associated Serious Adverse Reactions : An Analysis of the Thai Adverse Events Reporting System	P17.33	HIV testing, treatment and care
KashifUllah Khan	Survival trend and Impact of Adverse Drug Reactions during HAART on survival function In HIV/AIDS patients	P17.34	HIV testing, treatment and care
Grace Hoo	Cost-Effectiveness Analysis of Abacavir-Based and Tenofovir-Based Regimens in Singapore	P17.35	HIV testing, treatment and care
Heiko Jessen	Effectiveness, safety and tolerability profile of Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) in HIV-1-infected patients in the clinical setting	P17.36	HIV testing, treatment and care
Keishiro Yajima	Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive Japanese Patients with HIV-1 Infection	P17.37	HIV testing, treatment and care
Maureen Kimulwo	Plasma Drug Levels of Nevirapine Predict Virological Response In Patients Receiving Treatment In Kenyan Hospitals	P17.38	HIV testing, treatment and care
Ariyaratne Manathunge	Monitoring of the Scale-Up of the Antiretroviral Therapy Program in Sri Lanka: Experience from a Resource Limited and Low Prevalence Setting	P17.39	HIV testing, treatment and care
sang gede purnama	Strategic Use Of ARV program (SUFA) HIV-AIDS control efforts in High Risk Men in Denpasar, Bali	P17.40	HIV testing, treatment and care
Denis Chibuye	HIV and AIDS programming for people with disabilities on antiretroviral therapy (art) in Zambia	P17.41	HIV testing, treatment and care
Ivana Cristina Vieira de Lima	Scientific Production of Nursing Care About the Child Born Exposed to HIV	P17.42	HIV testing, treatment and care
Aisa Lee	Knowledge, Attitudes, and Coping of Healthcare Workers on HIV/AIDS and Persons Living with HIV in a Tertiary Hospital in Manila, Philippines	P17.43	HIV testing, treatment and care
Harry Tembo	An Assessment of HIV Knowledge among Traditional Birth Attendants in Rural Setting in Chipata, Zambia	P17.44	HIV testing, treatment and care
Tammy Rudduck	Assessing the use of a peer-led mobile van for effective HIV service delivery in regional Queensland: A whole of community approach.	P17.45	HIV testing, treatment and care
Olivia Waworuntu	The Implementation of PMTCT Program in Prof.Dr.R.D.Kandou Central Hospital, Manado -Indonesia.	P18.01	HIV prevention and social aspects
Laith Abu-Raddad	Circumcision of HIV positive males will not undermine the benefits of voluntary medical male circumcision programs in Africa	P18.02	HIV prevention and social aspects
Noah Kojima	Rapid training and implementation of the Pollock Technique, a safe, rapid and effective newborn circumcision procedure, in a low-resource setting	P18.03	HIV prevention and social aspects
Susanne Awad	A novel analytic framework to investigate voluntary medical male circumcision program efficiency gains through sub-population prioritization: Insights from application to Zambia	P18.04	HIV prevention and social aspects
Michel Alary	Contribution of Biomarkers to the Validation of Self-Reported Condom Use in a Treatment as Prevention and a Pre-Exposure Prophylaxis Demonstration Study among Female Sex Workers	P18.05	HIV prevention and social aspects
Michel Alary	Early Antiretroviral Therapy and Pre-Exposure Prophylaxis for HIV Prevention among Female Sex Workers in Cotonou, Benin: Early Follow-Up and Adherence Data	P18.06	HIV prevention and social aspects
Jacqueline Patruno	HIV Post-Exposure Prophylaxis in an Australian Regional Centre: Patient Demographics and Outcomes from 2011-2014	P18.07	HIV prevention and social aspects
Jennifer Kibicho	Pharmacists Perceptions Engaging in HIV Prevention Activities with Populations at-risk for HIV Infection	P18.08	HIV prevention and social aspects
Jennifer Kibicho	Community-based support groups engagement in HIV prevention and economic empowerment in rural Kenya	P18.09	HIV prevention and social aspects
Unnikrishnan Bhaskaran	Determinants of Quality of Life among People Living with Human Immunodeficiency Virus (PLHIV) in Coastal South India	P18.10	HIV prevention and social aspects
Chien-Tai Yu	Examining the effect of case management on levels of depression among newly diagnosed people living with hiv in taiwan	P18.11	HIV prevention and social aspects
Chien-Tai Yu	People seeking sexually transmitted diseases screening, medical professionals, and members of the general public surveyed regarding knowledge about non-occupational post-exposure prophylaxis for hiv	P18.12	HIV prevention and social aspects
Latesha Elopre	Reported Church Attendance at The Time of Entry Into HIV Care Associates With Reduced Viremia At 12 Months.	P18.13	HIV prevention and social aspects
Melissa Power	Sex Worker Outreach screening in Western Sydney:  early identification of a high-risk Population	P18.13A	Late addition
Jo-Anne Dillon	A POCT- Adaptable Test for the Simultaneous Identification of N. Gonorrhoeae and its Ciprofloxacin Susceptibility Status	P18.1$	Late addition